SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000898822-11-000287
Filing Date
2011-05-02
Accepted
2011-05-02 08:44:40
Documents
3
Period of Report
2011-04-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 talecris8kapril29.htm 8-K 25819
2 talecris8kexhibit.htm EX-99.1 10329
3 x0x0.jpg GRAPHIC 5583
  Complete submission text file 0000898822-11-000287.txt   45084
Mailing Address P.O. BOX 110526 RESEARCH TRIANGLE PARK NC 27709
Business Address 4101 RESEARCH COMMONS 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 919-316-6300
Talecris Biotherapeutics Holdings Corp. (Filer) CIK: 0001405197 (see all company filings)

IRS No.: 202533768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34473 | Film No.: 11797667
SIC: 2834 Pharmaceutical Preparations